All Stories

  1. Correction: Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome
  2. Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis
  3. Protocol to identify human subcellular alternative protein interactions using cross-linking mass spectrometry
  4. Development of a novel apigenin prodrug programmed for alkaline-phosphatase instructed self-inhibition to combat cancer
  5. Early Diagnosis: End-to-End CNN–LSTM Models for Mass Spectrometry Data Classification
  6. Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome
  7. Challenges in glioblastoma research: focus on the tumor microenvironment
  8. The IJMS Young Scientist Feature: A special article collection featuring perspectives and critical insights from early career mass spectrometrists around the globe
  9. Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
  10. Reduced finite element modelling and closed-loop control of pneumatic-driven soft continuum robots
  11. Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
  12. Sample preparation free tissue imaging using Laser Desorption – Rapid Evaporative Ionisation Mass spectrometry (LD-REIMS)
  13. Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study
  14. Establishment and characterization of canine mammary tumoroids for translational research
  15. Employing non-targeted interactomics approach and subcellular fractionation to increase our understanding of the ghost proteome
  16. From precise surgery to precision surgery: The multiple dimensions of therapeutic precision for head and neck cancer
  17. Challenges in glioblastoma research: focus on the tumor microenvironment
  18. Ambient Mass Spectrometry Imaging by Water-Assisted Laser Desorption/Ionization for Ex Vivo and in Vivo Applications
  19. Comparing MS imaging of lipids by WALDI and MALDI: two technologies for evaluating a common ground truth in MS imaging
  20. The IJMS Young Scientist Feature: A special article collection featuring perspectives and critical insights from early career mass spectrometrists from around the globe
  21. Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
  22. Establishment and characterization of a tumoroid biobank derived from dog patients’ mammary tumors for translational research
  23. The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury
  24. Direct In Vivo Analysis of CBD- and THC-Acid Cannabinoids and Classification of Cannabis Cultivars Using SpiderMass
  25. Spatial reference and alternative proteome analysis of glioblastoma reveals molecular signatures and associates survival with specific markers
  26. Mass Spectrometry-Based Differentiation of Oral Tongue Squamous Cell Carcinoma and Nontumor Regions With the SpiderMass Technology
  27. The Antibody Dependant Neurite Outgrowth Modulation Response (ADNM) involvement in Spinal Cord Injury
  28. Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion
  29. Path to Clonal Theranostics in Luminal Breast Cancers
  30. On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
  31. Direct<em> in vivo</em> Analysis of CBD- and THC-Acid Type Cannabinoids and Classification of <em>Cannabis</em> Cultivars by SpiderMass
  32. Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs
  33. Direct Water-Assisted Laser Desorption/Ionization Mass Spectrometry Lipidomic Analysis and Classification of Formalin-Fixed Paraffin-Embedded Sarcoma Tissues without Dewaxing
  34. Robot-Assisted SpiderMass for In Vivo Real-Time Topography Mass Spectrometry Imaging
  35. In Utero Exposure to Metformin Reduces the Fertility of Male Offspring in Adulthood
  36. Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
  37. Toward High Spatially Resolved Proteomics Using Expansion Microscopy
  38. Neurotrauma investigation through spatial omics guided by mass spectrometry imaging: Target identification and clinical applications
  39. In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
  40. Cancer Surgery 2.0: Guidance by Real-Time Molecular Technologies
  41. Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation
  42. Protein Kinase C Activation Drives a Differentiation Program in an Oligodendroglial Precursor Model through the Modulation of Specific Biological Networks
  43. Towards high spatially resolved microproteomics using expansion microscopy
  44. Shedding Light on the Ghost Proteome
  45. The NANOTUMOR consortium – Towards the Tumor Cell Atlas
  46. Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imaging
  47. Sarcoma Molecular Pathological Diagnosis of FFPE Tissues without Dewaxing based on Lipidomic Profiles using SpiderMass Technology
  48. Preneoplastic Lesions Fimbria Early Diagnosis Markers Underlying Timeline Mechanisms at The Origin of Ovarian Cancer in BRAC1/2 Patients: Case Reports Based on Proteogenomic Study
  49. Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages
  50. New Glioma Molecular Classification for Precise Therapeutic Decision Based on Spatially-Resolved Proteogenomics Guided by MALDI-MSI and Clinical Data Integration
  51. SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data
  52. Robot-Assisted SpiderMass for in vivo Real-Time Topography Mass Spectrometry Imaging
  53. Le parcours de soins du patient dans le cadre des CAR T-cell : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
  54. Overall patient’s survival of glioblastoma associated to molecular markers: a pan-proteomic prospective study
  55. OpenProt 2021: deeper functional annotation of the coding potential of eukaryotic genomes
  56. Cumulative learning enables convolutional neural network representations for small mass spectrometry data classification
  57. Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSC
  58. On-tissue spatially-resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
  59. Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10
  60. Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms
  61. The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth
  62. Reference and Ghost Proteins Identification in Rat C6 Glioma Extracellular Vesicles
  63. Alternative proteins are functional regulators in cell reprogramming by PKA activation
  64. Towards CNN Representations for Small Mass Spectrometry Data Classification: From Transfer Learning to Cumulative Learning
  65. A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program
  66. Mechanisms of innate events during skin reaction following intradermal injection of seasonal influenza vaccine
  67. Abstract P4-07-08: Functional proteomic characterization of early luminal breast cancers with discordant genomic and clinical risk estimates
  68. Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
  69. Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro
  70. Fast Cancer Molecular Diagnosis from FFPE Tissues Based on Metabolic Profiles Using SpiderMass Technology
  71. On-Tissue Spatially-Resolved Glycoproteomics Guided by N-Glycan Imaging Reveal Global Dysregulation of Canine Glioma Glycoproteomic Landscape
  72. Preneoplastic Lesions Fimbria Early Diagnosis Markers Underlying Timeline Mechanisms at the Origin of Ovarian Cancer in BRAC1/2 Patients
  73. Sentinel Lymph Node and Endometrial Cancer Grades, Molecular Markers Patients Stratification and Survival Diagnosis Identification
  74. Optimized Sample Preparation Workflow for Improved Identification of Ghost Proteins
  75. Water-assisted laser desorption/ionization mass spectrometry for minimally invasive in vivo and real-time surface analysis using SpiderMass
  76. The multiverse nature of epithelial to mesenchymal transition
  77. Nuclei of HeLa cells interactomes unravel a network of ghost proteins involved in proteins translation
  78. Canine Bone Marrow-derived Mesenchymal Stem Cells: Genomics, Proteomics and Functional Analyses of Paracrine Factors
  79. Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers
  80. Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease*
  81. Mass spectrometry-based intraoperative tumor diagnostics: a letter in reply
  82. The Brain Origin of Neonatal Microglia Determines the Content of Exosomes and Biological Function
  83. Abstract 2671: Omics unveils a specific signature of tumor dormancy in two murine models of leukemia and melanoma
  84. Overexpression of a Metallothionein 2A Gene from Date Palm Confers Abiotic Stress Tolerance to Yeast and Arabidopsis thaliana
  85. Distinct Protein Expression Networks are Activated in Microglia Cells after Stimulation with IFN-γ and IL-4
  86. Spinal Cord Injury: Animal Models, Imaging Tools and the Treatment Strategies
  87. Real time human micro-organisms biotyping based on Water-Assisted Laser Desorption/Ionization
  88. Optimizing the substrate-mediated laser ablation of biological tissues: Quest for the best substrate material
  89. A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program
  90. Utilisation of Ambient Laser Desorption Ionisation Mass Spectrometry (ALDI-MS) Improves Lipid-Based Microbial Species Level Identification
  91. Abstract P3-08-15: Proteomic profile of PAM50 intermediate risk early breast cancers
  92. Abstract P3-08-19: Proteomic tracking of breast cancer metastasis progression
  93. Proteomic characterisation of leech microglia extracellular vesicles (EVs): comparison between differential ultracentrifugation and Optiprep™ density gradient isolation
  94. The Protein Coded by a Short Open Reading Frame, Not by the Annotated Coding Sequence, Is the Main Gene Product of the Dual-Coding Gene MIEF1
  95. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial
  96. Real-Time Molecular Diagnosis of Tumors Using Water-Assisted Laser Desorption/Ionization Mass Spectrometry Technology
  97. 3D MALDI mass spectrometry imaging reveals specific localization of long-chain acylcarnitines within a 10-day time window of spinal cord injury
  98. OpenProt: a more comprehensive guide to explore eukaryotic coding potential and proteomes
  99. Real time and in vivo pharmaceutical and environmental studies with SpiderMass instrument
  100. Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy
  101. Lipid Changes Associated with Traumatic Brain Injury Revealed by 3D MALDI-MSI
  102. Can real time molecular analyses change the paradigm of dog sarcoma diagnosis and classification?
  103. Shedding new light on spinal cord injury
  104. Temporally and spatially-resolved microproteomics and MALDI MSI lipidomic analysis for traumatic brain injury biomarker identification
  105. Correction: Cizkova, D., et al. Localized Intrathecal Delivery of Mesenchymal Stromal Cells Conditioned Media Improves Functional Recovery in A Rat Model of Contusive Spinal Cord Injury. Int. J. Mol. Sci. 2018, 19, 870
  106. Remote Atmospheric Pressure Infrared Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry of Proteins
  107. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy
  108. Localized Intrathecal Delivery of Mesenchymal Stromal Cells Conditioned Medium Improves Functional Recovery in a Rat Model of Spinal Cord Injury
  109. Paclitaxel treatment and PC1/3 knockdown in macrophages is a promising anti-glioma strategy as revealed by proteomics and cytotoxicity studies
  110. Proteomic expression profile of injured rat peripheral nerves revealed biological networks and processes associated with nerve regeneration
  111. Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy
  112. Real-Time Molecular Diagnosis and Margin Definition of Tumors Based on a Novel Laser-Based Mass Spectrometry Technology
  113. The Origin of Microglia Determines the Content of Exosomes and Biological Function
  114. The Origin of Microglia Determines the Content of Exosomes and Biological Function
  115. ATP Modifies the Proteome of Extracellular Vesicles Released by Microglia and Influences Their Action on Astrocytes
  116. Spatially-Resolved Top-down Proteomics Bridged to MALDI MS Imaging Reveals the Molecular Physiome of Brain Regions
  117. Deep transcriptome annotation enables the discovery and functional characterization of cryptic small proteins
  118. Small Proteins Encoded by Unannotated ORFs are Rising Stars of the Proteome, Confirming Shortcomings in Genome Annotations and Current Vision of an mRNA
  119. β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells
  120. Integrated mass spectrometry imaging and omics workflows on the same tissue section using grid-aided, parafilm-assisted microdissection
  121. Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer
  122. Abstract 367: Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells
  123. RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis
  124. Deep transcriptome annotation suggests that small and large proteins encoded in the same genes often cooperate
  125. Laser induced post-desolvation of MALDI clusters
  126. Droplet-Based Liquid Extraction for Spatially-Resolved Microproteomics Analysis of Tissue Sections
  127. Combined MALDI Mass Spectrometry Imaging and Parafilm-Assisted Microdissection-Based LC-MS/MS Workflows in the Study of the Brain
  128. Progress and Potential of Imaging Mass Spectrometry Applied to Biomarker Discovery
  129. A Proteomic Analysis of Human Uterine Myoma
  130. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification
  131. NanoLC-MS coupling of liquid microjunction microextraction for on-tissue proteomic analysis
  132. Proteomic and transcriptomic investigation of acne vulgaris microcystic and papular lesions: Insights in the understanding of its pathophysiology
  133. On-tissue Direct Monitoring of Global Hydrogen/Deuterium Exchange by MALDI Mass Spectrometry: Tissue Deuterium Exchange Mass Spectrometry (TDXMS)
  134. Proprotein convertase 1/3 inhibited macrophages: A novel therapeutic based on drone macrophages
  135. Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair
  136. From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials)
  137. In vivo Real-Time Mass Spectrometry for Guided Surgery Application
  138. Spatially-resolved protein surface microsampling from tissue sections using liquid extraction surface analysis
  139. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics
  140. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways
  141. Substrate-Mediated Laser Ablation under Ambient Conditions for Spatially-Resolved Tissue Proteomics
  142. Reciprocal immune benefit based on complementary production of antibiotics by the leech Hirudo verbana and its gut symbiont Aeromonas veronii
  143. Inter- and intra-organ spatial distributions of sea star saponins by MALDI imaging
  144. Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair
  145. Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study
  146. Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer’s disease
  147. MALDI-MS and NanoSIMS imaging techniques to study cnidarian–dinoflagellate symbioses
  148. Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers
  149. Modulation properties of factors released by bone marrow stromal cells on activated microglia: an in vitro study
  150. Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication
  151. Mass spectrometry imaging and tissue microproteomic for clinical applications
  152. Lipidomics for Clinical Diagnosis: Dye-Assisted Laser Desorption/Ionization (DALDI) Method for Lipids Detection in MALDI Mass Spectrometry Imaging
  153. Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study
  154. HFIP Extraction Followed by 2D CTAB/SDS-PAGE Separation: A New Methodology for Protein Identification from Tissue Sections after MALDI Mass Spectrometry Profiling for Personalized Medicine Research
  155. Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target
  156. Alterations of protein composition along the rostro-caudal axis after spinal cord injury: proteomic, in vitro and in vivo analyses
  157. Human temporal lobe epilepsy analyses by tissue proteomics
  158. On the Origin of Increased Sensitivity and Mass Resolution Using Silicon Masks in MALDI
  159. Spectroimmunohistochemistry: A Novel Form of MALDI Mass Spectrometry Imaging Coupled to Immunohistochemistry for Tracking Antibodies
  160. Quantification-Based Mass Spectrometry Imaging of Proteins by Parafilm Assisted Microdissection
  161. Interactions entre coordination nationale de greffe et coordinateurs locaux
  162. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer
  163. Microproteomics by liquid extraction surface analysis: Application to FFPE tissue to study the fimbria region of tubo-ovarian cancer
  164. Ionic matrices pre-spotted matrix-assisted laser desorption/ionization plates for patient maker following in course of treatment, drug titration, and MALDI mass spectrometry imaging
  165. Development of liquid microjunction extraction strategy for improving protein identification from tissue sections
  166. Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech
  167. Correction: A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits
  168. A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits
  169. TARGETED MASS spectrometry Imaging: Specific Targeting Mass Spectrometry imaging technologies from history to perspective
  170. Ovarian cancer molecular pathology
  171. The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling
  172. Psychometric Validation of the PROQOL-HIV Questionnaire, a New Health-Related Quality of Life Instrument–Specific to HIV Disease
  173. The Development of PROQOL-HIV
  174. MALDI-MSI and Ovarian Cancer Biomarkers
  175. AMASS: Algorithm for MSI Analysis by Semi-supervised Segmentation
  176. Molecular Validation of PACE4 as a Target in Prostate Cancer
  177. Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer
  178. Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the Nervous System of the Medicinal Leech
  179. Automated Querying and Identification of Novel Peptides using MALDI Mass Spectrometric Imaging
  180. The triterpene glycosides of Holothuria forskali: usefulness and efficiency as a chemical defense mechanism against predatory fish
  181. MALDI Imaging Mass Spectrometry for Investigating the Brain
  182. Localization of Secondary Metabolites in Marine Invertebrates: Contribution of MALDI MSI for the Study of Saponins in Cuvierian Tubules of H. forskali
  183. MALDI Imaging and Profiling MS of Higher Mass Proteins from Tissue
  184. Epithelial–mesenchymal transition in ovarian cancer
  185. Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids
  186. On-tissue protein identification and imaging by MALDI-Ion mobility mass spectrometry
  187. Systems biology to battle vascular disease
  188. Specific MALDI-MSI: TAG-MASS
  189. MALDI Direct Analysis and Imaging of Frozen Versus FFPE Tissues: What Strategy for Which Sample?
  190. On Tissue Protein Identification Improvement by N-Terminal Peptide Derivatization
  191. Polymerase Chain Reaction and Immunoassay−Matrix Assisted Laser Desorption Mass Spectrometry Using Tag-Mass Technology: New Tools to Break Down Quantification Limits and Multiplexes
  192. On-Tissue N-Terminal Peptide Derivatizations for Enhancing Protein Identification in MALDI Mass Spectrometric Imaging Strategies
  193. Improving Tissue Preparation for Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging. Part 1: Using Microspotting
  194. MALDI Imaging Mass Spectrometry: STATE OF THE ART TECHNOLOGY IN CLINICAL PROTEOMICS
  195. MITICS (MALDI Imaging Team Imaging Computing System): A new open source mass spectrometry imaging software
  196. Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics
  197. MALDI Imaging of Formalin-Fixed Paraffin-Embedded Tissues: Application to Model Animals of Parkinson Disease for Biomarker Hunting
  198. The chain conformational order of ergosterol- or cholesterol-containing DPPC bilayers as modulated by Amphotericin B: a FTIR study
  199. Molecular MALDI imaging: An emerging technology for neuroscience studies
  200. Specific MALDI Imaging and Profiling for Biomarker Hunting and Validation:  Fragment of the 11S Proteasome Activator Complex, Reg Alpha Fragment, Is a New Potential Ovary Cancer Biomarker
  201. New Developments in MALDI Imaging for Pathology Proteomic Studies
  202. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
  203. Tag-Mass:  Specific Molecular Imaging of Transcriptome and Proteome by Mass Spectrometry Based on Photocleavable Tag
  204. Direct Analysis and MALDI Imaging of Formalin-Fixed, Paraffin-Embedded Tissue Sections
  205. Molecular Profiling of Native and Matrix-Coated Tissue Slices from Rat Brain by Infrared and Ultraviolet Laser Desorption/Ionization Orthogonal Time-of-Flight Mass Spectrometry
  206. Imagerie MALDI
  207. MALDI-MS Direct Tissue Analysis of Proteins:  Improving Signal Sensitivity Using Organic Treatments
  208. Solid Ionic Matrixes for Direct Tissue Analysis and MALDI Imaging
  209. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen
  210. 2-Cyano-3-(4-hydroxyphenyl)acrylic acid
  211. Delayed extraction experiments using a repulsing potential before ion extraction: evidence of non-covalent clusters as ion precursor in UV matrix-assisted laser desorption/ionization. Part II?Dynamic effects with ?-cyano-4-hydroxycinnamic acid matrix
  212. Silencing of SPC2 Expression Using an Engineered   Ribozyme in the Mouse  TC-3 Endocrine Cell Line
  213. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity
  214. Irradiation effects in MALDI, ablation, ion production, and surface modifications. Part II: 2,5-dihydroxybenzoic acid monocrystals
  215. The initial-ion velocity as a marker for different desorption-ionization mechanisms in MALDI
  216. Irradiation effects in MALDI and surface modifications
  217. Delayed extraction experiments using a repulsive potential before ion extraction: evidence of clusters as ion precursors in UV-MALDI. Part I: dynamical effects with the matrix 2,5-dihydroxybenzoic acid
  218. Post-source decay time-of-flight study of fragmentation mechanisms of protonated synthetic polymers under matrix-assisted laser desorption/ionization conditions
  219. Analyte Incorporation and Ionization in Matrix-Assisted Laser Desorption/Ionization Visualized by pH Indicator Molecular Probes
  220. Observation of micelle solution of decyltrimethylammonium bromide by electrospray ionization mass spectrometry
  221. Sequencing of a branched peptide using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
  222. Bis- and Tetrakis(organosilyl) Decatungstosilicate, [γ-SiW10O36(RSi)2O]4− and [γ-SiW10O36(RSiO)4]4−: Synthesis and Structural Determination by Multinuclear NMR Spectroscopy and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
  223. Bis- and Tetrakis(organosilyl) Decatungstosilicate, [-SiW10O36(RSi)2O]4 and [-SiW10O36(RSiO)4]4: Synthesis and Structural Determination by Multinuclear NMR Spectroscopy and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry